Course Provider
Learning Objectives
Upon completion of this activity, participants should be better able to discuss barriers and solutions to timely access to care, including earlier identification and treatment of patients with solid tumors
Upon completion of this activity, participants should be better able to design appropriate treatment strategies based on biomarker testing results and other patient- and disease-specific factors
Upon completion of this activity, participants should be better able to differentiate novel therapies based on the latest clinical trial data and current guideline recommendations
Upon completion of this activity, participants should be better able to identify adverse events associated with novel therapies and take steps to mitigate their effects
Upon completion of this activity, participants should be better able to employ expert strategies to improve communication, education, and treatment decision-making with patients